With the recent disclosure of its second-quarter financial results, TradockBy the first half of 2022, the company’s losses had ballooned to nearly $10 billion.
telehealth giant Provision for impairment charges A $6.6 billion write-down in the first quarter to write down its $18.5 billion value i’m in love acquisition, it finalized Fall 2020, the company’s second quarter Another $3 billion in fees Write down the value of the transaction.
As expected, Teladoc shares fell after the report set lower expectations for its 2022 financial outlook. Berenberg Capital Markets analyst Dev Weerasuriya downgraded Teladoc to “hold” from “buy” and lowered his price target range to $35 to $42. Goldman Sachs analyst Cindy Motz downgraded the stock to “neutral” from “buy” and lowered his price target to $36 from $55.
Ali Parsa, CEO of Teladoc rival Babylon Health, said in an interview that this changing economic landscape has provided big telehealth companies with a chance to rearrange spending to focus on improving technology to better support predictive and preventive health. Chance
He said Teladoc could use what Amazon did 20 years ago as an example of how to navigate a relentless economic environment. Around 2001, Amazon lost about 90% of its market value, which basically meant its cost of capital increased tenfold. In response, the company organized spending to ensure more expensive funds were spent on areas that differentiated the company from competitors — a time for the company to focus on e-commerce, Parsa said. In his view, it was this period that really made the company.
Teladoc has the potential to drive similar initiatives by investing in technology. To be successful, telehealth companies must now differentiate themselves by the ability to remotely track patient health, provide personalized care recommendations, and intervene before health problems escalate to the point of requiring expensive acute treatment, Parsa said. Telehealth companies that fail to do so will be “commoditized by the competition,” he said.
He also noted that Teladoc’s loss was a direct result of the company’s decision to pay an “incredible amount” for Livongo two years ago.
Livongo founder Glen Tullman is sending Medical City News. He said the idea seemed reasonable at the time, but “like anything in life – sports, business, etc. – it all comes down to execution.”
Tullman – now CEO transparenta digital health platform for self-insured employers – states that when The news broke first Teladoc and Livongo will merge, Livongo also Announcement of financial results Q2 2020 on the same morning.
“What may have been obscured by all the media coverage of the merger is that Livongo was profitable a year early,” he said. “We achieved triple-digit growth with over 1,500 leading employers using our Whole Person Service and over 1 million members. The company peaked across all business metrics. And, I would say, Livongo’s brand is digital health The strongest brand in the industry.”
While the huge valuation for him at the moment makes sense, Tullman admits that “it’s clear that the momentum isn’t holding up and the culture, talent and market leadership that Livongo has built is lost in many ways.”
Lee Shapiro, former CFO of Livongo, current managing partner 7wire Ventures, arguing that Teladoc’s financial adjustment has more to do with the overall decline in the company’s stock price and other publicly traded digital health companies than the underlying health of its business.He said he remains confident that telehealth will continue to play a key role in long-term care services, especially for behavioral health.
Teladoc CEO Jason Gorevic made a similar point on the second-quarter earnings call. He said his company’s financial loss was “due to heightened uncertainty in the broader economic backdrop, particularly as it relates to trends and consumer spending and its impact on our direct-to-consumer business.”
Photo: Jaiz Anuar, Getty Images
